Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nafazatrom

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nafazatrom in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(nafazatrom)
Trials
(nafazatrom)
Recent Studies (post-2010) (nafazatrom)
9,1561875529250

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)nafazatrom (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseRattus norvegicus (Norway rat)6.1667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moodley, I; Stuttle, A1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nafazatrom

ArticleYear
Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes.
    Prostaglandins, 1987, Volume: 33, Issue:2

    Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Cell Aggregation; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Male; Neutrophils; Platelet Activating Factor; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains

1987